|
|
Changes and clinical significance of miR-126 and sVCAM-1 levels in patients with coronary artery heart disease |
YANG Nanran1 WANG Xiaoqun1 LIU Xiaohui1 FANG Bingxiong2 |
1.Department of Cardiovascular, Puning People′s Hospital, Guangdong Province, Puning 515300, China;
2.Laboratory Department, Puning People′s Hospital, Guangdong Province, Puning 515300, China |
|
|
Abstract Objective To investigate the changes and clinical significance of plasma miR-126 and soluble vascular cell adhesion molecule-1 (sVCAM-1) levels in patients with coronary artery heart disease (CHD). Methods One hundred and three cases of CHD patients hospitalized in Puning People′s Hospital of Guangdong Province from February 2018 to December 2019 were selected. They were divided into acute coronary syndrome (ACS) of 58 cases and stable angina pectoris (SAP) of 45 cases according to the diagnostic criteria, and 55 non-CHD patients were selected as the control group. All patients underwent coronary angiography and the Gensini′s degree integral method was used to evaluate coronary artery stenosis. The plasma miR-126 and sVCAM-1 levels were measured, and Pearson correlation coefficient was used for correlation analysis. Results The levels of sVCAM-1 and Gensini′s degree integral score in ACS group were significantly higher than those of SAP group and control group, the levels of miR-126 were all lower than those of SAP group and control group (P < 0.05). And the level of miR-126 in SAP group was lower than that of control group, the Gensini′s degree integral score was higher than that of control group (P < 0.05). The levels of miR-126 in patients with multiple coronary artery lesions and moderate to severe disease were respectively lower than those in patients with single coronary artery lesion and mild disease (P < 0.05). The levels of sVCAM-1 in patients with multiple coronary artery lesions and moderate to severe disease were respectively higher than those in patients with single coronary artery lesion and mild disease (P < 0.05). Correlation analysis showed that miR-126 was negatively correlated with the number of coronary artery lesions (r = -0.536, P = 0.007) and Gensini′s degree integral score (r = -0.574, P = 0.015). sVCAM-1 was positively correlated with the number of coronary artery lesions (r = 0.619, P = 0.000) and Gensini′s degree integral score (r = 0.644, P = 0.000). miR-126 was negatively correlated with sVCAM-1 (r = -0.685, P = 0.000). Conclusion There are significant down-regulation of miR-126 expression and up-regulation of sVCAM-1 expression in CHD patients, and the indexes are closely related to the degree of coronary lesions, which may be used as reference indicators for the diagnosis and treatment of CHD.
|
|
|
|
|
[1] 申文祥,李琚平,牛锁成,等.阿托伐他汀治疗冠心病前后患者血浆黏附因子浓度变化的观察[J].临床医学,2017, 37(1):17-18.
[2] 王彩蕊,任凤学,刘祎秀,等.冠心病患者冠状动脉病变进展的相关危险因素的探讨[J].心肺血管病杂志,2020, 39(1):14-18.
[3] 陈秋霞,姜醒华.冠心病生物标志物的研究进展[J].医学综述,2015,21(2):222-224.
[4] 冯晓敏,刘玉薇,万楠.miR-126与冠心病关系研究进展[J].临床军医杂志,2018,46(7): 848-850.
[5] 曾萍,杨简.miRNA在冠心病检测中的研究新进展[J].中国老年学杂志,2017,37(1):233-235.
[6] 杨莉,何燕,杨文慧,等.双源螺旋CT结合外周血管超声和炎性标志物评价老年2型糖尿病合并冠心病患者冠脉斑块的稳定性[J].中国老年学杂志,2015,35(7):1747-1749.
[7] 梁芳,马玉梅,魏德芝,等.稳消方对颈动脉粥样硬化不稳定斑块MCP-1、VCAM-1表达、脂质代谢、踝臂指数的影响[J].现代中西医结合杂志,2015,24(22):2400-2402,2427.
[8] 中华医学会心血管病学分会,中华心血管病杂志编辑委员会.急性ST段抬高型心肌梗死诊断和治疗指南[J].中华心血管病杂志,2015,38(8):675-690.
[9] Amsterdam EA,Wenger NK,Brindis RG,et al. 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes:a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines [J]. Circulation,2014,130(25):e344-e426.
[10] 中华医学会心血管病学分会,中华心血管病杂志编辑委员会.中国心血管病预防指南[J].柳州医学,2012,5(4):263-279.
[11] 朱小莉,周云,孙晓靖.冠心病危险因素分析及其与冠状动脉狭窄程度的关系[J].中国循证心血管医学杂志,2017,9(12):1513-1515.
[12] 金鹏,周琪,康美丽,等.高迁移率族蛋白B1与冠心病病变程度和斑块易损性相关性[J].中华实用诊断与治疗杂志,2017,31(6):574-576.
[13] 王阳,米树华,杨关林.动脉粥样硬化机制研究进展[J].中国医药,2017,12(4):619-623.
[14] 田海萍,赵冠南,郑俊华,等.脂联素、血管内皮细胞黏附分子1和同型半胱氨酸水平与冠心病患者冠状动脉粥样硬化斑块类型的相关性研究[J].实用心脑肺血管病杂志,2018,26(1):22-26.
[15] 耿驰,陶梦醒,刘莹.血管细胞黏附分子-1在心血管疾病中的研究进展[J].心血管病学进展,2019,40(2):222-226.
[16] 方叶青,谢培益,王磊,等.冠心病患者循环内皮祖细胞变化及功能的研究[J].中国动脉硬化杂志,2019,27(8):694-699.
[17] Brown RA,Shantsila E,Varma C,et al. Current Understanding of Atherogenesis [J]. Am J Med,2017,130(3):268-282.
[18] 赵雨轩,徐赟晟,倪晶宇,等.血管细胞黏附分子-1与动脉粥样硬化机制的研究现状[J].中国临床药理学杂志,2018,34(12):1481-1483.
[19] 周立宾,薛红,刘娟.冠心病患者外周血miR-126与sVCAM-1表达及相关性研究[J].临床和实验医学杂志,2019,18(9):923-926.
[20] Lu TX,Rothenberg ME. MicroRNA [J]. J Allergy Clin Immunol,2018,141(4):1202-1207.
[21] Feinberg MW,Moore KJ. MicroRNA Regulation of Ather-osclerosis [J]. Circ Res,2016,118(4):703-720.
[22] 李亚丽,姜皓,艾丽萍,等.循环microRNAs在冠心病中的诊断作用[J].中国实验诊断学,2018,22(9):1665-1667.
[23] Wu H,Zhang J. miR-126 in Peripheral Blood Mononuclear Cells Negatively Correlates with Risk and Severity and is Associated with Inflammatory Cytokines as well as Intercellular Adhesion Molecule-1 in Patients with Coronary Artery Disease [J]. Cardiology,2018,139(2):110-118.
[24] 李云,宋银宏,吕云波.miR-126与血管的研究进展[J].基础医学与临床,2015,35(2):257-261.
[25] Tian HS,Zhou QG,Shao F. Relationship between arterial atheromatous plaque morphology and platelet-associated miR-126 and miR-223 expressions [J]. Asian Pac J Trop Med,2015,8(4):309-314. |
|
|
|